Stockreport

Provectus Biopharmaceuticals Announces Poster Presentation of Rose Bengal Sodium for Treatment of Full-Thickness Cutaneous Wounds at SID 2024 Annual Meeting [Yahoo! Finance]

PROVECTUS BIOPHARMS  (PVCT) 
NASDAQ:AMEX Investor Relations: provectusbio.com/financial-overview
PDF the “Company”) (OTCQB: PVCT) today announced that non-clinical data on Provectus's proprietary, pharmaceutical-grade, rose bengal sodium (“RBS”) active pharmaceutical in [Read more]